Mannkind (MNKD) Free Cash Flow (2010 - 2026)
Mannkind (MNKD) posted quarterly Free Cash Flow of -$5.6 million for Q1 2026, up 16.03% year-over-year from -$4.9 million in Q1 2025, and up 27.35% quarter-over-quarter from -$7.8 million in Q4 2025.
Mannkind (MNKD) Free Cash Flow (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has reported Free Cash Flow for 17 consecutive years, with -$5.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow rose 16.03% year-over-year to -$5.6 million; the TTM figure through Mar 2026 stood at $18.7 million (down 37.27% YoY), while the FY2025 annual figure was $17.6 million, down 56.81% from the prior year.
- Free Cash Flow climbed to -$5.6 million in Q1 2026 per MNKD's latest filing, from -$7.8 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $24.3 million in Q3 2025 and bottomed at -$32.5 million in Q2 2022.
- Historically, Free Cash Flow has averaged $191882.4 across 5 years, with a median of $4.3 million in 2024.
- Annual changes were most pronounced in 2023 — Free Cash Flow surged 1102.99% — and 2025, when it plunged 256.16%.
- Mannkind's Free Cash Flow stood at -$2.2 million in 2022, then soared by 1102.99% to $22.5 million in 2023, then declined by 0.12% to $22.5 million in 2024, then sank by 134.53% to -$7.8 million in 2025, then rose by 27.35% to -$5.6 million in 2026.
- Business Quant data shows MNKD's Free Cash Flow at -$5.6 million in Q1 2026, -$7.8 million in Q4 2025, and $24.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -389.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 437.80 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 477.44 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 292.04 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Mannkind | 1.19 Bn | 1.08 Bn | 94.97 Mn | -23.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -23.45 Mn |
| Jun 30, 2026 | -23.45 Mn |
| Mar 31, 2026 | -5.63 Mn |
| Mar 31, 2026 | -5.63 Mn |
| Dec 31, 2025 | -7.75 Mn |
| Dec 31, 2025 | -7.75 Mn |
| Sep 30, 2025 | 24.26 Mn |
| Sep 30, 2025 | 24.26 Mn |
| Jun 30, 2025 | 7.83 Mn |
| Jun 30, 2025 | 7.83 Mn |
| Mar 31, 2025 | -6.71 Mn |
| Mar 31, 2025 | -6.71 Mn |
| Dec 31, 2024 | 22.45 Mn |
| Dec 31, 2024 | 22.45 Mn |
| Sep 30, 2024 | 9.25 Mn |
| Sep 30, 2024 | 9.25 Mn |
| Jun 30, 2024 | 4.84 Mn |
| Jun 30, 2024 | 4.84 Mn |
| Mar 31, 2024 | 4.30 Mn |
| Mar 31, 2024 | 4.30 Mn |